Japan concludes contract with Pfizer to procure 144M doses of covid vaccines in 2021
|Commenting on Pfizer’s coronavirus vaccine, Japanese Health minister Norihisa Tamura said that they have concluded a contract with the US drugmaker to procure 144 million doses of vaccines in 2021.
“The supply contract is on condition that Pfizer’s vaccine is approved in Japan,” he was quick to add.
The minister said that he hoped the Pfizer’s coronavirus vaccine would be approved in mid-February.
Prime Minister Yoshihide Suga said last week that the government was preparing to start the inoculation program in late February, adding that local governments were readying vaccination centers.
Related reads
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.